God is our Guide  Number 1 site for helping reverse diseases on Planet Earth
cidpUSA Foundation

 cidpusa.org   

      

 
Home
Diagnosis
Treatment
Pathology
Variants
CIDP info
Fibromyalgia
IVIG
 Anti-inflammatory Diet
Burning  Feet Home
Services Page
Chronic Fatigue
Autoimmune diseases
Prognosis
Bible healing
Celiac disease
Spinal Injury Green tea

Inflammation receptor

CIDP articles

CIDP-neuropathy

Multi Focal Motor neuropathy

M.M.F.

Lewis Summer

Tips for CIDP

Axonal EMG

CIDP-EMG

Dr Katz -CIDP

Plasmapheresis

CIDP-INFO

Treatment of alcoholic poly neuropathy

IgG subclass deficiency

IgG deficiency

Natural Makeup
Neck Pain
Ocular Female diseases
Chronic fatigue syndrome
Osteoporosis
Women Heart Attacks
Spices
Cure all diseases
Vinegar
Memory problems
Breast Lymph Drainage
Kidney stone Buster
Bras cause breast cancer
Skin repair Clinic
Pandas
Hepatitis

 Immune Inflammation switch   genes  CIDPUSA Foundation

   alternatives treatment of autoimmune disease read our e-book 

Special Medical Search
Australian National University

The discovery of how a particular gene in the human body suppresses autoimmune diseases like Type 1 diabetes and lupus could open the way for a completely new approach to treating such conditions, scientists propose.

Around one in eight Australians suffer from autoimmune diseases, which occur when the body’s T and B cells attack its own organs and tissues. In 2005 Dr Carola Vinuesa and Professor Chris Goodnow from The Australian National University discovered that such pathologies were linked to the gene Roquin, which can undergo a specific mutation that results in it instructing T cells to react against the self. Now the researchers lead an international team that reports in the journal Nature on exactly how a healthy Roquin gene prevents abnormal T-cell behavior.

“Our findings hinge on the fact that the activities of a normal Roquin gene are orchestrated by parts of the genome until very recently considered to be "junk DNA",” said Dr Vinuesa from the John Curtin School of Medical Research (JCSMR) at ANU.

The discovery centres on a form of RNA, or Ribo Nucleic Acid. Most RNAs are thought of as messengers that carry information from a cell’s DNA blueprint so it can be written into proteins, the building-blocks of cells and tissues. But not all RNAs act as a messenger. Some small, non-protein-coding forms of the material, called microRNAs, actually induce the decay of messenger RNAs.

“This decay leads to reduction of the expression of proteins such as one called ICOS, that we have now shown can result in autoimmunity when it is over-expressed,” said Dr Di Yu from JCSMR, who performed most of the experiments leading to the discovery. “This is the first time that microRNAs have been linked to protection from autoimmune diseases.”

Once considered to be genetic junk, microRNAs are now thought to regulate up to 30 per cent of the genome, and have been recently shown to play an important role in the development of cancer and other diseases. “More and more scientists are beginning to think of genes as ‘RNA factories’,” said JCSMR’s Professor Chris Goodnow, who is also the Director of the Australian Phenomics Facility at ANU. “We’re learning more and more about how RNAs regulate critical processes related to cell development and the evolution of complex structures like the brain.”

The researchers said their work opened up the possibility of using RNA interference, or the microRNAs themselves, in the treatment of autoimmune diseases.

Some things have been said, yet so much more cannot be written about. See this message from God.


  


 

 
 

>  

  

Sand Bath

 Glutathione

 Sulphur Bath

 

 Quran page